MedPath

LEMTRADA

LEMTRADA

Approved
DIN Number

02418320

Drug Class

Human

Market Date

Jan 29, 2014

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02418320
AIG Number0151562001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AG06 ALEMTUZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALEMTUZUMABActive
Strength: 12 MG / 1.2 ML
Monograph: ALEMTUZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.